Nilo-PD Study

[--Ton--]

FYI---

The following sites are currently enrolling participants for the Nilo-PD study:

Milwaukie Lexington, Tampa, Durham, Ann Arbor, Boston, Phoenix, Houston, Aurora, Las Vegas, Gainesville, Philadelphia, Portland, Cleveland, New York, Chicago, Birmingham, Cincinnati, East Lansing, Memphis, Charleston, and Baltimore. Simply login to foxtrialfinder.org or ask me for the contact name.

[RS313]

Hello,

I live in Michigan not to far from Ann Arbor, what is this study about and what is the criteria to be able to participate? thanks so much! Robyn

[--Ton-- in reply to RS313]

Hi Robyn... The study is now in the second stage. The objective is to determine if the already FDA approved drug (used for chronic myelogenous leukemia), can be repurposed to eliminate our Alpha-synuclein build up in Parkinson's patients. The study is restricted to the USA, they are looking for people with Parkinson's between the ages of 40 - 79 and have moderate to advanced Parkinson's disease (diagnosed 5+ years). For more information call University of Michigan, Angela Stovall 734-647-4787 or log into foxtrialfinder.michaeljfox.com. Thank you for showing an interest. -Toni

[movinngroovin]

Yes please explain more. Charlottsville VA is not on this listing.

[--Ton-- in reply to movinngroovin]

Good Morning--Sorry you didn't receive yesterday's note. You may call University of Virginia, Katie Sullivan, 434-982-6599 or log into foxtrialfinder.michaeljfox.com

The study is in its second stage. Their objective is to determine if the already FDA approved drug used to treat chronic Myelogenous leukemia can be repurposed reducing the Alpha synuclein protein clumping. The qualifying factors: they're looking for people between the ages of 40 and 79, who have moderate to advanced Parkinson's disease (diagnosed 5+ years). The study is restricted to the USA.

Thank you for showing an interest.